Skip to content

Clinical trials

Phase 3 Glioblastoma trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 3 Country / region: Austria Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20062
20082
20091
20111
20151
20181
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting4
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC2
NovoCure Ltd.2
AbbVie1
AstraZeneca1
CarThera1
Celldex Therapeutics1
Eli Lilly and Company1
Isarna Therapeutics GmbH1
Pfizer1
Precision Life Sciences Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma14
Brain Neoplasms6
Neoplasms4
Gliosarcoma2
Astrocytoma1
Central Nervous System Neoplasms1
Glioma1
Neoplasm Recurrence, Local1
Recurrence1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.